SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-057453
Filing Date
2018-11-06
Accepted
2018-11-06 18:11:35
Documents
1
Period of Report
2018-11-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6455
  Complete submission text file 0001209191-18-057453.txt   8100
Mailing Address 1701 TRINITY STREET SUITE 3.322 AUSTIN TX 78712
Business Address 1701 TRINITY STREET SUITE 3.322 AUSTIN TX 78712 512-708-0155
Genprex, Inc. (Issuer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1701 TRINITY STREET SUITE 3.322 AUSTIN TX 78712
Business Address 1701 TRINITY STREET SUITE 3.322 AUSTIN TX 78712 512-708-0155
Genprex, Inc. (Reporting) CIK: 0001595248 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38244 | Film No.: 181164231
SIC: 2834 Pharmaceutical Preparations